Princeton, NJ, United States of America

Henry Shen

USPTO Granted Patents = 3 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Henry Shen: Innovator in Immunology and Biotechnology**

Introduction

Henry Shen is a prominent inventor based in Princeton, NJ, known for his significant contributions to the field of immunology and biotechnology. With a total of three patents to his name, Shen has established himself as a key player in advancing technologies that modulate immune responses, particularly those relating to T-cells.

Latest Patents

Shen's latest inventions revolve around polynucleotides encoding BSL2v2c2 and BSL2v2c2-Ig. These patents detail the provision of nucleic acids encoding B7-related factors that play a crucial role in modulating the activation of immune and inflammatory response cells, such as T-cells. The innovations further encompass expression vectors, fusion constructs, isolated B7-related polypeptides, and antibodies that are specifically reactive with these polypeptides. Moreover, the inventions introduce assays that utilize B7-related nucleic acids, polypeptides, or peptides, proving valuable for immunomodulation in human and animal subjects.

Career Highlights

Henry Shen is currently employed at Bristol-Myers Squibb Company, where his work contributes to novel therapeutic strategies in the realm of immune modulation. His expertise and innovative thinking have led to patents that not only advance scientific understanding but also have practical applications in medical treatments.

Collaborations

In his professional journey, Shen collaborates with talented individuals including Glen Eugene Mikesell and Han Chang. These collaborations enhance the research initiatives and drive innovative projects that aim to tackle complex challenges in immunology and biomedicine.

Conclusion

Through his significant contributions and innovative patents, Henry Shen has made remarkable strides in the field of immunology. His work at Bristol-Myers Squibb, coupled with collaboration with esteemed colleagues, positions him as a leading inventor dedicated to harnessing the power of biotechnology to improve health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…